The True Explanation for the Popularity of Ozempic-Like Weight-Loss Medications

Overweight and obesity rates have reached crisis levels and are risk factors for various diseases such as diabetes, heart disease, cancer, dementia, and more. The CDC estimates that almost a third of Americans are now overweight, and 42% of adults have obesity, which is now categorized as a disease. Childhood obesity is also on the rise, with one in five children estimated to be affected. This is not just an American crisis, as the World Obesity Federation predicts that more than half of the world’s population will be overweight or obese within the next 12 years.

The causes of this epidemic include sedentary lifestyles, the food and beverage environment, eating out more frequently, lack of safe places for physical activity, genetics, and certain medications. However, new highly popular GLP 1 weight loss drugs such as Ozempic, Wegovy, and Mounjaro have entered the market. These drugs have gained attention, with Oprah Winfrey even doing a TV special on the topic. She emphasizes that obesity is a disease and highlights the effectiveness of these drugs in her weight loss journey.

Brian Kay of Numerator reports that 12% of respondents in their household panel are using one of the new GLP 1 drugs for diabetes and/or weight loss. The data also shows that consumers are consuming smaller portion sizes, resulting in a decrease in grocery bills. However, one major issue that consumers face is the cost of these drugs, leading many to discontinue usage.

The financial implications of the obesity crisis are profound, affecting various industries such as food and beverage, restaurants, health insurance companies, and Medicare. The total cost in terms of health care, lost productivity, corporate insurance, and long-term care is immense.

In recent decades, food consumption has skyrocketed, with portion sizes increasing significantly. Many restaurant chains compete on volume meals, and consumers often equate volume with value, leading to considerable waste. The issue of hyper-palatable foods, which are engineered to trigger cravings and overeating, has also contributed to the obesity crisis.

Changing consumer behavior is challenging, with many individuals confused, misguided, or indifferent about eating healthier. Portion control has been highlighted as a promising strategy for promoting a healthier lifestyle. The Portion Balance Coalition, led by the Business for Impact Center at Georgetown University, aims to reduce obesity and improve health by advocating for smaller portion sizes.

Hank Cardello, the chair of the Portion Balance Coalition, points out the „stubborn roadblocks“ to positive change, emphasizing that taste is a significant factor in consumers‘ food choices. Recent research by the Coalition and the Natural Marketing Institute revealed different consumer segments, with some being more responsive to smaller portions than others.

Overall, portion balance emerges as a promising strategy to address the obesity and food waste crises. Companies that offer more choices and reasonable portions can enhance consumer appeal, improve margins, and maintain taste. The importance of promoting healthier eating habits and addressing the root causes of obesity cannot be understated in tackling this global health crisis.